St. Petersburg, FL5 Active Studies

Advanced Solid Tumors Clinical Trials in St. Petersburg, FL

Find 5 actively recruiting advanced solid tumors clinical trials in St. Petersburg, FL. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
975
Enrolling

Recruiting Advanced Solid Tumors Studies in St. Petersburg

RecruitingSt. Petersburg, FLNCT05579366

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that ha...

569 participants
Genmab
View Study Details
RecruitingSt. Petersburg, FLNCT06695845

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors that have Human Epidermal Growth Factor Receptor ...

200 participants
Jazz Pharmaceuticals
View Study Details
RecruitingSt. Petersburg, FLNCT05277168

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to determine maximum tolerated dose (MTD) and/or...

83 participants
Jiangsu HengRui Medicine Co., Ltd.
View Study Details
RecruitingSt. Petersburg, FLNCT04870944

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors or lymphoma that has c...

63 participants
Children's Oncology Group
View Study Details
RecruitingSt. Petersburg, FLNCT01804634

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and shortened duration tacrolimus is safe and feasible for pa...

60 participants
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
View Study Details

About Advanced Solid Tumors Clinical Trials in St. Petersburg

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 5 advanced solid tumors clinical trials recruiting participants in St. Petersburg, FL. These studies are seeking a combined 975 participants. Research is being sponsored by Genmab, Jazz Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in St. Petersburg — FAQ

Are there advanced solid tumors clinical trials in St. Petersburg?

Yes, there are 5 advanced solid tumors clinical trials currently recruiting in St. Petersburg, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St. Petersburg?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you about next steps.

Are clinical trials in St. Petersburg free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St. Petersburg studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 5 active trials in St. Petersburg are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov